Pharmacogenomically selected treatment for gastric and gastroesophageal (GEJ) tumors: a phase II study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Pharmacogenomic; Therapeutic Use
- 07 Jan 2016 Biomarkers information updated
- 24 Dec 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 12 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.